Wang Liang Selected Research

Wang Liang Research Topics

4	Neoplasms (Cancer) 01/2021 - 09/2009
2	Carcinogenesis 08/2019 - 09/2009
2	Infections 07/2013 - 04/2011
2	Glomerulonephritis 12/2009 - 11/2008
1	Inflammation (Inflammations) 01/2021
1	Pathologic Processes 08/2019
1	Intracranial Aneurysm (Cerebral Aneurysm) 02/2019
1	Neuroblastoma 09/2014
1	Atherosclerotic Plaque (Atheroma) 09/2013
1	Obesity 12/2010
1	Weight Gain 12/2010
1	Pre-Eclampsia (Preeclampsia) 06/2010
1	Neoplasm Metastasis (Metastasis) 09/2009
1	Acute Lung Injury 01/2008
1	Brain Ischemia (Cerebral Ischemia) 07/2004

3	lipoprotein-associated coagulation inhibitor (TFPI)IBA 12/2009 - 01/2008
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 09/2013 - 06/2010
1	NF-kappa B (NF-kB)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 08/2019
1	5,6,7,8- tetrahydro- 4H- isoxazolo(4,5- d)azepin- 3- olIBA 08/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2019
1	erucylphosphocholineIBA 02/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	acetamideIBA 09/2014
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 09/2014
1	Protein Kinase InhibitorsIBA 09/2014
1	Matrix Metalloproteinases (MMPs)IBA 09/2013
1	Apolipoproteins E (ApoE)IBA 09/2013
1	nemonoxacinIBA 07/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2011
1	LipidsIBA 12/2010
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2010
1	Thromboplastin (Tissue Factor)IBA 06/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Peptides (Polypeptides)IBA 12/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	NeuroserpinIBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2004
1	Plasminogen Activator Inhibitor 1IBA 07/2004
1	Neuroprotective AgentsIBA 07/2004
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2004

1	Drug Therapy (Chemotherapy) 08/2019